Steris (FRA:2TG) Cyclically Adjusted Revenue per Share: €41.81 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2TG Steris PLC FRA:2TG
83 GF Score
Price €189.70
GF Value €233.49
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Steris Cyclically Adjusted Revenue per Share?

Steris FRA:2TG +8.09% 83 Cyclically Adjusted Revenue per Share is €41.81 as of Mar. 2026. GuruFocus rates FRA:2TG with a GF Score™ of 83/100 and a GF Value™ of €233.49 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Steris's adjusted revenue per share for the three months ended in Mar. 2026 was €13.963. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €41.81 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Steris's average Cyclically Adjusted Revenue Growth Rate was 8.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.20% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Steris was 18.20% per year. The lowest was 2.70% per year. And the median was 5.50% per year.

As of today (2026-07-19), Steris's current stock price is €189.70. Steris's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €41.81. Steris's Cyclically Adjusted PS Ratio of today is 4.54.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Steris was 7.36. The lowest was 2.60. And the median was 5.15.


Steris  (FRA:2TG) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Steris's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=189.70/41.81
=4.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Steris was 7.36. The lowest was 2.60. And the median was 5.15.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Steris Cyclically Adjusted Revenue per Share Related Terms


Steris Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Steris's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Steris Cyclically Adjusted Revenue per Share Chart

Steris Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.59 35.42 32.48 34.20 41.81

Steris Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.20 32.92 39.20 39.72 41.81

FRA:2TG vs ZBH, DXCM, PEN: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Steris's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Steris Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Steris's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Steris's Cyclically Adjusted PS Ratio falls into.


FRA:2TG
83GF Score
Steris PLC FRA:2TG
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Steris Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Steris's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=13.963/127.8300*127.8300
=13.963

Current CPI (Mar. 2026) = 127.8300.

Steris Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 6.567 101.072 8.306
201609 6.671 100.274 8.504
201612 7.169 99.676 9.194
201703 7.406 100.374 9.432
201706 6.312 100.673 8.015
201709 6.196 100.474 7.883
201712 6.525 100.075 8.335
201803 6.788 100.573 8.628
201806 6.394 101.072 8.087
201809 6.807 101.371 8.584
201812 7.163 100.773 9.086
201903 7.957 101.670 10.004
201906 7.207 102.168 9.017
201909 7.807 102.268 9.758
201912 8.138 102.068 10.192
202003 8.694 102.367 10.857
202006 6.933 101.769 8.708
202009 7.478 101.072 9.458
202012 7.729 101.072 9.775
202103 8.528 102.367 10.649
202106 8.834 103.364 10.925
202109 10.105 104.859 12.319
202112 10.612 106.653 12.719
202203 7.648 109.245 8.949
202206 10.862 112.779 12.312
202209 12.129 113.504 13.660
202212 11.460 115.436 12.690
202303 8.889 117.609 9.661
202306 11.006 119.662 11.757
202309 11.671 120.749 12.355
202312 11.978 120.749 12.680
202403 13.111 120.990 13.852
202406 11.958 122.318 12.497
202409 12.070 121.594 12.689
202412 13.234 122.439 13.817
202503 13.862 123.405 14.359
202506 12.207 124.492 12.534
202509 12.593 124.810 12.898
202512 12.959 125.770 13.171
202603 13.963 127.830 13.963

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €41.81 mean?
Steris (FRA:2TG) has a Cyclically Adjusted Revenue per Share of €41.81 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Steris and its competitors.
Is Steris' Cyclically Adjusted Revenue per Share too high?
Steris' current Cyclically Adjusted Revenue per Share is €41.81. Overall, Steris has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Steris' Cyclically Adjusted Revenue per Share compare to ZBH and DXCM?
Steris' Cyclically Adjusted Revenue per Share of €41.81 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Steris and its competitors. Steris's current Cyclically Adjusted Revenue per Share is €41.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Steris stock overvalued right now?
Based on GuruFocus' analysis, Steris (FRA:2TG) is currently considered Modestly Undervalued. The stock's GF Value™ is €233.49, compared to a current price of €189.70 — trading 18.8% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €41.81. Steris' overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Steris (FRA:2TG), the current Cyclically Adjusted Revenue per Share is €41.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Steris (FRA:2TG) Overvalued in 2026?

Based on GuruFocus' analysis, Steris stock appears to be undervalued. The current stock price of €189.70 is trading 18.8% below its estimated GF Value™ of €233.49. GuruFocus considers Steris to be Modestly Undervalued.

Key valuation signals for FRA:2TG:

  • Cyclically Adjusted Revenue per Share: €41.81
  • GF Value™: €233.49 vs. price of €189.70 (18.8% below fair value)
  • GF Score™: 83/100 with 1 warning sign

No single metric tells the full story. See the FRA:2TG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Steris Business Description

Other Exchanges STE:USAS1TE34:Brazil
Address 70 Sir John Rogerson\'s Quay, Dublin, IRL, D02 R296
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
83GF Score

Get the complete analysis for FRA:2TG

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€189.70
Price
€233.49
GF Value